Evidence map›Paper›PMID 20235520›Full record

ArticleThe journal of physical chemistry. B2010

Determination of the phase diagram for soluble and membrane proteins.

Sameer Talreja, Sarah L Perry, Sudipto Guha, Venkateswarlu Bhamidi, Charles F Zukoski, Paul J A Kenis

Open access · greenAbstract read
In one paragraph

Article in The journal of physical chemistry. B, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 31 citations in OpenAlex.

  1. Investigating the Effects of Nanogels in Promoting Protein Crystallization.International journal of molecular sciences · 2026
    Article
  2. Phase Diagrams as a DOE Tool in Biomolecular Crystallization.Advances in biochemical engineering/biotechnology · 2026
    Review
  3. Quantitative Perspectives of Biomolecular Crystallization Thermodynamics.Advances in biochemical engineering/biotechnology · 2026
    Review
  4. Article
  5. Computational crystallization.Archives of biochemistry and biophysics · 2016
    Review
  6. Article
  7. Crystallization screening: the influence of history on current practice.Acta crystallographica. Section F, Structural biology communications · 2014
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sameer TalrejaDepartment of Chemical & Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA.
Sarah L Perry
Sudipto Guha
Venkateswarlu Bhamidi
Charles F Zukoski
Paul J A Kenis
University of Illinois Urbana-Champaign · US

Funding

Case Center for Synchrotron BiosciencesP30EB009998 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI CHANCE, MARK R · 2009 to 2018
$8.4M
On-Chip Crystallization and In Situ X-ray Analysis of Membrane ProteinsR01GM086727 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI KENIS, PAUL J. A. · 2009 to 2011
$1.0M
Innovative Methods for Membrane Protein CrystallizationR21GM075930 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI KENIS, PAUL J A · 2005 to 2006
$358k
Microfluidic Membrane Protein Crystallization for HIgh Resolution ProteomicsF31EB008330 · NIBIB · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI PERRY, SARAH LOUISE · 2008 to 2009
$82k
NIBIB NIH HHS F31 EB008330NIBIB NIH HHS P30 EB009998NIGMS NIH HHS R01 GM086727NIGMS NIH HHS R21 GM075930NIGMS NIH HHS R21 GM075930-01
6 · The paper itself

Abstract

Methods to efficiently determine the phase behavior of novel proteins have the potential to significantly benefit structural biology efforts. Here, we present protocols to determine both the solubility boundary and the supersolubility boundary for protein/precipitant systems using an evaporation-based crystallization platform. This strategy takes advantage of the well-defined rates of evaporation that occur in this platform to determine the state of the droplet at any point in time without relying on an equilibrium-based end point. The dynamic nature of this method efficiently traverses phase space along a known path, such that a solubility diagram can be mapped out for both soluble and membrane proteins while using a smaller amount of protein than what is typically used in optimization screens. Furthermore, a variation on this method can be used to decouple crystal nucleation and growth events, so fewer and larger crystals can be obtained within a given droplet. The latter protocol can be used to rescue a crystallization trial where showers of tiny crystals were observed. We validated both of the protocols to determine the phase behavior and the protocol to optimize crystal quality using the soluble proteins lysozyme and ribonuclease A as well as the membrane protein bacteriorhodopsin.

Indexed as

BacteriorhodopsinsCrystallizationMuramidaseRibonuclease, PancreaticSolubilityBacteriorhodopsinsMuramidaseRibonuclease, Pancreatic

Identifiers

PMID20235520
PMCPMC2848416
OpenAlexW2115380987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.